Diagnostic Evaluation of Inhalant Allergies: A Cost-effectiveness Analysis

Lewis, Andrea F.; Franzese, Christine B.; Stringer, Scott P.

doi:10.2500/ajr.2008.22.3163

Cited by 8 publications

(4 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Specifically, we recorded the number of studies that used either cost‐effective(ness) or cost‐benefit in the title or abstract but were not true economic evaluations. Following the application of the inclusion and exclusion criteria, a total of 50 studies were evaluated using the QHES instrument 12‐61 …”

Section: Methodsmentioning

confidence: 99%

Systematic Review of the Quality of Economic Evaluations in the Otolaryngology Literature

Liu

Lui

Paolucci

et al. 2014

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Systematic Review of the Quality of Economic Evaluations in the Otolaryngology Literature

Liu

Lui

Paolucci

et al. 2014

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

show abstract

“…Disadvantages include the additional risk and time involved in placing intradermal tests. MQT has been shown to be more cost‐effective when the prevalence of AR in a population is 20% or higher when compared to IDT and in vitro testing methods 1206,1282 …”

Section: Evaluation and Diagnosismentioning

confidence: 99%

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Wise

Damask

Roland

et al. 2023

Int Forum Allergy Rhinol

Self Cite

115

View full text Add to dashboard Cite

Background In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document. Methods ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.

show abstract

“…It is important to highlight that allergy testing demonstrates sensitization to a specific allergen, which does not always imply clinical manifestations of that sensitization (54,55) . Despite their relatively high cost compared to skin prick tests (SPT), tests that measure serum levels of allergen specific IgE are a valuable alternative for patients with a high risk of anaphylaxis, severe eczema or other dermatologic diseases, or when the interruption of anti-histamines is contraindicated (56) .…”

Section: Allergic Rhinitismentioning

confidence: 99%

European position paper on diagnostic tools in rhinology

Rimmer

Hellings

Lund

et al. 2019

Rhin

114

View full text Add to dashboard Cite

is the official Journal of the European and International Rhinologic Societies and appears quarterly in March, June, September and December. Cited in Pubmed, Current Contents, Index Medicus, Exerpta Medica and Embase Founded in 1963 by H.A.E. van Dishoeck, Rhinology is a worldwide non-profit making journal. The journal publishes original papers on basic research as well as clinical studies in the major field of rhinology, including physiology, diagnostics, pathology, immunology, medical therapy and surgery of both the nose and paranasal sinuses. Review articles and short communications are also pulished. All papers are peer-reviewed. Letters-to-the-editor provide a forum for comments on published papers, and are not subject to editorial revision except for correction of English language. In-depth studies that are too long to be included into a regular issue can be published as a supplement. Supple ments are not subject to peer-review.

show abstract

Diagnostic Evaluation of Inhalant Allergies: A Cost-effectiveness Analysis

Cited by 8 publications

References 21 publications

Systematic Review of the Quality of Economic Evaluations in the Otolaryngology Literature

Systematic Review of the Quality of Economic Evaluations in the Otolaryngology Literature

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

European position paper on diagnostic tools in rhinology

Contact Info

Product

Resources

About